Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04275908 · ClinicalTrials.gov registry record
Classification and Assessment of Mental Health Performance Using Schematics
A clinical trial of Suicide Ideation and Suicidal Intention, sponsored by Clarigent Health.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT04275908: Completed study of Suicide Ideation and Suicidal Intention, sponsored by Clarigent Health.
NCT04275908 is a study of Suicide Ideation and Suicidal Intention that has completed, run by Clarigent Health. The registered enrollment target is 22 participants, below the 387-participant average among 7 other Suicide Ideation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04275908, a study of Suicide Ideation and Suicidal Intention, has completed, sponsored by Clarigent Health.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open enrollment study to collect data for the optimization of smartphone-based algorithms for the early detection of mental health and suicidal risk in a student population. Approximately 2000 students, ages 8-23, will be recruited by therapists across 30 schools and mental health centers.
Primary Outcome
Participants will be asked about their mental health using standardized questionnaires and a specific set of additional questions developed to encourage an open conversation with the therapist. The app will record the therapy session and a proprietary algorithm will be tested to determine if it can accurately detect the presence of a mental state (for example, suicidal intention) as compared with the standardized questionnaires (e.g. Columbia scale) and the therapists' clinical impression.
Conditions Studied
Interventions
- DEVICE MHSAFE app
Study Locations (1)
Ohio
- Clarigent Health - Mason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2023-01-01 |
What the finished NCT04275908 record still lists
NCT04275908 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 387-participant average among 7 other Suicide Ideation trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Suicide Ideation appearing as the primary indexed condition, and to 1 intervention - of which MHSAFE app is the first listed.
NCT04275908 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04275908 about?
NCT04275908 is a clinical study titled "Classification and Assessment of Mental Health Performance Using Schematics". This is an open enrollment study to collect data for the optimization of smartphone-based algorithms for the early detection of mental health and suicidal risk in a student population. Approximately 2000 students, ages 8-23, will be recruited by therapists across 30 schools and mental health centers...
What is the current status of trial NCT04275908?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2020-01-01. Estimated completion is 2023-01-01.
What conditions does trial NCT04275908 study?
This clinical trial studies the following conditions: Suicide Ideation, Suicidal Intention, Suicide and Depression.
What interventions are being tested in trial NCT04275908?
The interventions under investigation include: MHSAFE app (DEVICE).
Who is sponsoring clinical trial NCT04275908?
This trial is sponsored by Clarigent Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04275908 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Ideation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior
RECRUITING · NA
-
A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
RECRUITING · NA
-
Caring Connections Youth Suicide Detection and Intervention Study
RECRUITING · NA
-
Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors
RECRUITING · NA
-
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
RECRUITING · NA
-
Smartphone App Enhanced Facilitation Among Veterans in a Mental Health Inpatient Setting (Project HOPE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI